Pingshuan Dong Selected Research

Pingshuan Dong Research Topics

Disease

9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2014
5	Essential Hypertension 01/2022 - 04/2014
4	Thrombosis (Thrombus) 08/2014 - 10/2013
3	Hypertension (High Blood Pressure) 01/2021 - 01/2015
3	Myocardial Infarction 05/2014 - 06/2013
2	Reperfusion Injury 09/2021 - 02/2018
2	Type 2 Diabetes Mellitus (MODY) 07/2020 - 01/2019
2	Body Weight (Weight, Body) 07/2020 - 01/2019
2	Acute Coronary Syndrome 01/2020 - 01/2016
2	ST Elevation Myocardial Infarction 06/2014 - 06/2013
1	Ischemia 09/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2021
1	Hypoxia (Hypoxemia) 09/2021
1	Wounds and Injuries (Trauma) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Weight Loss (Weight Reduction) 07/2020
1	Cardiotoxicity 06/2020
1	Heart Diseases (Heart Disease) 06/2020
1	Death (Near-Death Experience) 01/2016
1	Heart Failure 01/2016
1	Anemia 01/2016
1	Myxoma (Myxomas) 05/2015
1	Atrial Fibrillation 12/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2013

Drug/Important Bio-Agent (IBA)

3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 07/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 06/2020 - 05/2015
2	Everolimus FDA Link 06/2014 - 05/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Long Noncoding RNAIBA 09/2021
1	puerarinIBA 09/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Liraglutide FDA Link 07/2020
1	Biological ProductsIBA 06/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020
1	HydrogelsIBA 06/2020
1	Sericins (Sericin)IBA 06/2020
1	ferric oxide (iron oxide)IBA 06/2020
1	olmesartanIBA 05/2019
1	azilsartanIBA 05/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	LipidsIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	candesartanIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	empagliflozinIBA 01/2019
1	Telmisartan (Micardis)FDA Link 01/2019
1	fasudil (AT 877)IBA 02/2018
1	Prasugrel Hydrochloride FDA Link 11/2017
1	TicagrelorIBA 11/2017
1	Cystatin CIBA 08/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 04/2017
1	HematinicsIBA 01/2016
1	omega-Chloroacetophenone (Mace)IBA 01/2016
1	MEF2 Transcription FactorsIBA 05/2015
1	Messenger RNA (mRNA)IBA 05/2015
1	3' Untranslated Regions (3' UTR)IBA 05/2015
1	AldehydesIBA 01/2015
1	ThrombomodulinIBA 01/2015
1	Aldehyde DehydrogenaseIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2014
1	PolymersIBA 08/2014
1	Pharmaceutical PreparationsIBA 06/2014
1	MetalsIBA 06/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2014
1	Sirolimus (Rapamycin)FDA Link 05/2014
1	zotarolimusIBA 05/2014
1	Met Transfer RNAIBA 04/2014
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2014
1	Plasminogen Activator Inhibitor 1IBA 01/2014
1	Tirofiban (Aggrastat)FDA Link 10/2013
1	Thymidine Monophosphate (TMP)IBA 10/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2014
4	Percutaneous Coronary Intervention 01/2020 - 06/2013
3	Drug-Eluting Stents 08/2014 - 05/2014
3	Stents 08/2014 - 05/2014
1	Catheters 01/2022
1	Denervation 01/2022
1	Chronotherapy 01/2021
1	Glycemic Control 01/2015
1	Electric Countershock (Cardioversion) 12/2014
1	Counterpulsation (External Counterpulsation) 06/2013